Scarica l'app Stockscreener
4.00
2.44%
-0.10
Dopo l'orario di chiusura:
4.05
0.05
+1.25%
Precedente Chiudi:
$4.10
Aprire:
$4.09
Volume 24 ore:
74,310
Relative Volume:
0.53
Capitalizzazione di mercato:
$70.55M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-4.2553
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
+0.00%
1M Prestazione:
-2.44%
6M Prestazione:
+105.13%
1 anno Prestazione:
+86.05%
Intervallo 1D:
$4.00
$4.26
Intervallo di 1 settimana:
$3.8731
$4.26
Portata 52W:
$1.3003
$6.22
Exagen Inc Stock (XGN) Company Profile
Nome
Exagen Inc
Settore
Industria
Telefono
(760) 560-1501
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Confronta XGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
4.00 | 70.55M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
597.75 | 228.64B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
222.74 | 160.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
151.52 | 43.27B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
201.36 | 36.55B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
422.05 | 34.56B | 3.84B | 866.24M | 792.60M | 10.37 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-04-15 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-06-02 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Iniziato | Cowen | Outperform |
| 2019-10-14 | Iniziato | William Blair | Outperform |
Mostra tutto
Exagen Inc Borsa (XGN) Ultime notizie
Short Interest in Exagen Inc. (NASDAQ:XGN) Drops By 90.7% - MarketBeat
Exagen Inc. (NASDAQ:XGN) Short Interest Down 90.7% in January - Defense World
Cantor Fitzgerald Decreases Earnings Estimates for Exagen - Defense World
FY2024 EPS Estimates for Exagen Lowered by Cantor Fitzgerald - MarketBeat
Exagen Gains 28%, Insider Trades Reap Benefit - Yahoo Finance
The 26% return this week takes Exagen's (NASDAQ:XGN) shareholders one-year gains to 102% - Simply Wall St
Exagen Inc. (XGN) Soars to 52-Week High, Time to Cash Out? - MSN
Exagen Inc. Gains Approval for Advanced Lupus and Rheumatoid Arthritis Diagnostic Tests - Lupus Foundation of America
Exagen’s (XGN) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World
Cantor Fitzgerald Reaffirms "Overweight" Rating for Exagen (NASDAQ:XGN) - MarketBeat
Exagen Inc. Secures Conditional NY State Approval for New - GlobeNewswire
Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis - The Bakersfield Californian
Exagen Achieves Record $55.8M Revenue, Gets NY Approval for New Lupus & RA Biomarker Tests - StockTitan
Exagen (NASDAQ:XGN) Given New $7.00 Price Target at Canaccord Genuity Group - Defense World
Exagen (NASDAQ:XGN) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
Short Interest in Exagen Inc. (NASDAQ:XGN) Grows By 36.5% - Defense World
Exagen Inc. (NASDAQ:XGN) Short Interest Up 36.5% in December - MarketBeat
Exagen (NASDAQ:XGN) Stock Price Up 1.4%Time to Buy? - MarketBeat
Exagen (NASDAQ:XGN) Trading 1.4% Higher – Still a Buy? - Defense World
Exagen Inc.'s (NASDAQ:XGN) Share Price Boosted 26% But Its Business Prospects Need A Lift Too - Simply Wall St
Learn to Evaluate (XGN) using the Charts - Stock Traders Daily
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD - GlobeNewswire
Exagen Hits Major Milestone: 1 Million AVISE Tests Revolutionize Autoimmune Disease Diagnosis - StockTitan
Exagen stock soars to 52-week high, hits $4.97 - Investing.com
Exagen's SWOT analysis: diagnostic firm's stock poised for growth amid challenges By Investing.com - Investing.com South Africa
Exagen's SWOT analysis: diagnostic firm's stock poised for growth amid challenges - Investing.com India
Exagen stock soars to 52-week high, hits $4.88 amid robust gains By Investing.com - Investing.com South Africa
Exagen stock soars to 52-week high, hits $4.88 amid robust gains - Investing.com Canada
Wasatch Advisors LP Sells 272,054 Shares of Exagen Inc. (NASDAQ:XGN) - MarketBeat
Exagen stock holds Sector Weight amid mixed 3Q24 results By Investing.com - Investing.com Nigeria
Exagen stock soars to 52-week high, hits $3.79 By Investing.com - Investing.com Canada
Exagen CEO, President & Director Acquires 7.7% More Stock - Simply Wall St
Exagen stock soars to 52-week high, hits $3.79 - Investing.com India
Exagen CFO Jeffrey Black acquires $66,448 in common stock - Investing.com India
Exagen CFO Jeffrey Black acquires $66,448 in common stock By Investing.com - Investing.com UK
Exagen president and CEO John Aballi buys $68,297 in stock By Investing.com - Investing.com Canada
Exagen president and CEO John Aballi buys $68,297 in stock - Investing.com
What is William Blair’s Forecast for Exagen FY2024 Earnings? - Defense World
Research Analysts Issue Forecasts for Exagen FY2024 Earnings - MarketBeat
FY2024 EPS Estimates for Exagen Raised by Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Increases Earnings Estimates for Exagen - Defense World
Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
William Blair Reiterates “Outperform” Rating for Exagen (NASDAQ:XGN) - Defense World
Exagen unveils new biomarkers to enhance autoimmune testing - Investing.com
Exagen Inc. Completes Validation and Regulatory Submission - GlobeNewswire
Exagen Enhances AVISE CTD Platform with 7 New Biomarkers for Autoimmune Disease Detection | XGN Stock News - StockTitan
Exagen Inc Azioni (XGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.69%
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):